UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
'Xolair’s reimbursement will change treatment paradigm for asthma patients'
Novartis Korea will be able to strengthen its position in the severe allerg...
by Lee Han-soo
|
2020-07-09 18:11
라인
Drugmakers appeal limited insurance benefit for dementia drug choline alfoscerate
Sixty-six manufacturers of choline alfoscerate, a dementia drug, filed an a...
by Kim Chan-hyuk
|
2020-07-09 12:52
라인
‘Hypertension drug Opsumit enhances right ventricle function’
Opsumit (ingredient: macitentan), a pulmonary arterial hypertension (PAH) t...
by Shim Hyun-tai
|
2020-07-08 16:59
라인
Crystal Genomics confirms safety of super-bacteria antibiotic candidate
Crystal Genomics said that it has completed the phase 1 clinical trial for ...
by Lee Han-soo
|
2020-07-08 16:58
라인
‘Study results on MSD’s Keytruda very disappointing’
Local experts expressed dissatisfaction with MSD’s Keynote-604 trial result...
by Kim Yun-mi
|
2020-07-07 16:43
라인
ITC ruling gives Medytox upper hand in BTX strain dispute
Medytox said Tuesday that the U.S. International Trade Commission ruled in ...
by Lee Han-soo
|
2020-07-07 11:47
라인
Daewoong to conduct P1 trial of Covid-19 treatment in Indonesia
Daewoong Pharmaceutical said that the Indonesian health regulators have app...
by Lee Han-soo
|
2020-07-06 16:52
라인
Regulator OKs Janssen's multiple myeloma treatment
Janssen Pharmaceutical said the Ministry of Food and Drug Safety has approv...
by Lee Han-soo
|
2020-07-06 15:48
라인
Experts showed mixed preferences between 2 diabetes treatments
Two classes of drugs -- sodium-glucose cotransporter-2 (SGLT2) inhibitors a...
by Kim Yun-mi
|
2020-07-06 14:20
라인
[News Focus] Who will win BTX strain dispute – Daewoong or Medytox?
The U.S. International Trade Commission (ITC) is to give a preliminary ruli...
by Kim Chan-hyuk
|
2020-07-06 11:50
라인
Crystal Genomics to start P2 trial of Covid-19 treatment
Crystal Genomics said that the Ministry of Food and Drug Safety has given t...
by Lee Han-soo
|
2020-07-02 18:07
라인
Boryung finds cancer drug has antiviral effect on Covid-19
Boryung Pharmaceutical said the company has found that Aplidin (ingredient:...
by Shim Hyun-tai
|
2020-07-02 18:07
라인
Heliximith unveiled how HX109 inhibits prostate hyperplasia
Heliximith said that HX109, its prostate hyperplasia (BPH) prevention and t...
by Lee Han-soo
|
2020-07-02 15:03
라인
MSD Korea reshuffles personnel before spinoff of Organon
MSD Korea has newly appointed key executives to lead each business unit bef...
by Kim Yun-mi
|
2020-07-02 13:44
라인
Novartis’ asthma drug gets insurance benefit
Novartis’ allergic asthma and chronic urticarial drug Xolair (ingredient: o...
by Shim Hyun-tai
|
2020-07-01 20:05
라인
Takeda Korea completes takeover of Shire Korea
Takeda Pharmaceuticals Korea announced Wednesday that it has completed the ...
by Lee Han-soo
|
2020-07-01 17:39
라인
Hanmi to export dyslipidemia drug to Mexico via MSD
Hanmi Pharmaceutical said Wednesday that its partner, MSD, has obtained mar...
by Shim Hyun-tai
|
2020-07-01 14:19
라인
Hanmi's short bowel syndrome treatment wins rare pediatric disease status
The U.S. Food and Drug Administration has granted a rare pediatric disease ...
by Lee Han-soo
|
2020-06-30 17:38
라인
Hugel submits NDA for BTX product in Europe
Hugel said that it has submitted a new drug application (NDA) in Europe for...
by Lee Han-soo
|
2020-06-30 15:36
라인
KPBMA to expand local drugmakers’ exchanges with Europe
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) s...
by Kim Chan hyuk
|
2020-06-30 14:09
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top